Treatment challenge was initiated with regular colchicine administration, and genetic counseling was provided. MEFV gene analysis revealed L110P-E148Q, a compound heterozygous mutation in MEFV exon 2 (NCBI NM_000243.3), confirming the diagnosis of FMF caused by exon 2 mutations. This evidence concerns the gene MEFV and familial Mediterranean fever.